BUZIO, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 3.763
EU - Europa 3.340
AS - Asia 1.359
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 4
SA - Sud America 1
Totale 8.524
Nazione #
US - Stati Uniti d'America 3.661
CN - Cina 1.051
IE - Irlanda 687
UA - Ucraina 574
SE - Svezia 572
FI - Finlandia 541
IT - Italia 459
DE - Germania 306
TR - Turchia 166
SG - Singapore 122
GB - Regno Unito 110
CA - Canada 100
CI - Costa d'Avorio 48
NL - Olanda 22
BE - Belgio 19
AT - Austria 14
FR - Francia 11
IN - India 9
EU - Europa 8
IL - Israele 4
RO - Romania 4
AU - Australia 3
ES - Italia 3
JP - Giappone 3
PT - Portogallo 3
RU - Federazione Russa 3
CH - Svizzera 2
CZ - Repubblica Ceca 2
IR - Iran 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
BO - Bolivia 1
DK - Danimarca 1
GL - Groenlandia 1
HR - Croazia 1
IM - Isola di Man 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MX - Messico 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PL - Polonia 1
TW - Taiwan 1
Totale 8.524
Città #
Dublin 686
Chandler 656
Jacksonville 641
Dearborn 336
Beijing 277
Ashburn 232
Nanjing 202
Ann Arbor 176
Izmir 154
Princeton 149
San Mateo 129
Wilmington 112
Toronto 90
Parma 76
Singapore 72
Boardman 65
Shanghai 57
Woodbridge 56
Shenyang 51
Kunming 50
Nanchang 50
Abidjan 48
New York 48
Hebei 44
Hefei 44
Jinan 40
Helsinki 37
Tianjin 36
Bremen 30
Los Angeles 28
Des Moines 26
Rome 23
Changsha 22
Guangzhou 22
Jiaxing 22
Houston 21
Brussels 19
Milan 18
Auburn Hills 17
Norwalk 15
Fremont 14
Kocaeli 12
Seattle 12
Vienna 12
Zhengzhou 9
Ningbo 8
Falls Church 7
Haikou 7
Ansbach 6
Fuzhou 6
Lanzhou 6
Leiden 6
Rockville 6
Wenzhou 6
Wuhan 6
Dallas 5
Hangzhou 5
Napoli 5
Pisa 5
Rapolla 5
Taizhou 5
Torino 5
Ardea 4
Atlanta 4
Augusta 4
Bologna 4
Brescia 4
Catania 4
Pescara 4
Pune 4
Rio Saliceto 4
Verona 4
Baotou 3
Cutrofiano 3
Fairfield 3
Jesi 3
Madrid 3
Montréal 3
Nocera Inferiore 3
Ottawa 3
Qingdao 3
Redmond 3
Redwood City 3
Tel Aviv 3
Venezia 3
Andover 2
Avellino 2
Borås 2
Bratislava 2
Bresso 2
Brugherio 2
Bucharest 2
Buscoldo 2
Cagliari 2
Carugate 2
Changchun 2
Chongqing 2
Coimbra 2
Düsseldorf 2
Faenza 2
Totale 5.144
Nome #
Miocardite eosinofila in corso di sindrome ipereosinofila idiopatica: descrizione di un caso 201
Periaortite cronica e vasculite dei piccoli vasi 197
Anti-fibroblast antibodies in patients with idiopathic retroperitoneal fibrosis 105
The kidney donor profile index (KDPI) of marginal donors allocated by standardized pretransplant donor biopsy assessment: Distribution and association with graft outcomes 102
Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. 101
PROTEIN-INDUCED CHANGES IN KIDNEY-FUNCTION DEPEND ON THE TIME OF ADMINISTRATION BUT NOT ON THE DIETARY SOURCE 98
Periaortite cronica e vasculite dei piccoli vasi: studio morfologico-clinico 98
ANCA-positive periaortic vasculitis: does it fall within the spectrum of vasculitis? 92
Candida sake as the causative agent of spondylodiscitis in a hemodialysis patient. 84
Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies 80
Churg-Strauss syndrome. 79
Sirolimus plus prednisone for Erdheim-Chester disease: An open-label trial 79
La poliangite microscopica 76
HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome 76
Granulomatosi di Wegener 75
Sullo spostamento del rapporto pressione arteriosa/natriuresi valutato nella fase pre-ipertensiva del modello sperimentale dei ratti spontaneamente ipertesi (SHR) 75
Autoantibodies to fibroblasts in systemic sclerosis 74
CC chemokine receptor 5 polymorphism in chronic periaortitis. 74
EBV-associated leukoencephalopathy with late onset of central nervous system lymphoma in a kidney transplant recipient. 74
PTPN22 R620W polymorphism in the ANCA-associated vasculitides. 73
Asbestos and Smoking as Risk Factors for Idiopathic Retroperitoneal Fibrosis 73
L’interessamento del sistema nervoso periferico nelle vasculiti ANCA associate 72
Immunoglobulin G inhibit endothelial activation induced by atherogenic stimuli 72
IL TRATTAMENTO DEL LAPAROCELE NEL PAZIENTE TRAPIANTATO DI RENE 72
Trends in Immune Cell Function Assay and Donor-Specific HLA Antibodies in Kidney Transplantation: A 3-Year Prospective Study 71
Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature 71
Early proinflammatory activation of renal tubular cells by normal and pathologic IgG 69
Prognostic significance of albuminuria in patients with renal cell cancer 69
Treatment of Erdheim-Chester disease with sirolimus. Report of a case” (Poster) 69
Immunoglobulins G inhibit endothelial activation induced by atherogenic stimuli 68
Chronic periaortitis associated with membranous nephropathy: clues to common pathogenetic mechanisms. 68
Chronic periaortitis: a spectrum of diseases 67
Il tubulo-interstizio e il riassorbimento delle proteine filtrate 66
Efficacy of a Regimen of Chronic Low Dose of Interleukin-2 (IL-2) and a-Interferon (INF-a) in Metastatic Renal Cell Cancer (MRCC) 66
Chronic periaortitis and HLA–DRB1*03: Another clue to an autoimmune origin 66
Screening of helicobacter pylori infection in acquired glomerular nephropathies: preliminary results 65
Anti-fibroblast antibodies in retroperitoneal fibrosis 65
Large bowel obstruction heralding Churg-Strauss syndrome 64
Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin 64
OCTREOTIDE IN THE TREATMENT OF LYMPHORREA AFTER RENAL TRANSPLANTATION: A PRELIMINARY EXPERIENCE 64
Association of serum C3 concentration and histologic signs of thrombotic microangiopathy with outcomes among patients with ANCA-associated renal vasculitis 64
Long-term treatment with low doses of interleukin-2 and interferon-alpha: immunological effects in advanced renal cell cancer 63
Respiratory system involvement in ANCA-associated systemic vasculitides 63
Chronically administered immunotherapy with low-dose IL-2 and IFN-α in metastatic renal cell carcinoma: A feasible option for patients with a good prognostic profile 63
Evidence of autoimmunity in chronic periaortitis: a prospective study 62
Ear, nose and throat manifestations of Churg-Strauss syndrome. 62
Idiopathic and secondary forms of retroperitoneal fibrosis: A diagnostic approach 62
Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome 62
Interferon-alfa in combination with ribavirin as initial treatment for HCV-associated membranoproliferative glomerulonephritis 61
Increased viral load after intravenous immunoglobulin therapy for BK virus-associated nephropathy 61
Glutathione S-transferases M1-1 and T1-1 as risk modifiers for renal cell cancer associated with occupational exposure to chemicals 61
Normal human IgG prevents endothelial cell activation induced by TNFalpha and oxidized low-density lipoprotein atherogenic stimuli 60
Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. 60
Chronic periaortitis with thoracic aorta and epiaortic artery involvement: a systemic large vessel vasculitis? 60
Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: Insights into mechanisms of myocardial cell death 59
Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis 59
Tamoxifene e fibrosi retroperitoneale 58
Immunoterapia con basse dosi di rIL-2 e rIFN alfa nel carcinoma a cellule renali metastatico: effetti immunologici 58
A randomised trial of tamoxifen and prednisone in idiopathic retroperitoneal fibrosis 58
Albuminuria as prognostic factor in renal cell cancer 57
Retroperitoneal fibrosis 57
Outcome and prognostic factors during the course of primary small-vessel vasculitides. 57
Orofacial granulomatosis treated with low-level laser therapy: a case report 57
Subclinical interstitial lung abnormalities in stable renal allograft recipients in the era of modern immunosuppression. 57
(18)F-flurodeoxyglucose positron emission tomography in the diagnosis and follow-up of idiopathic retroperitoneal fibrosis 56
Neuropatie vasculitiche: uno studio prospettico clinico ed elettrofisiologico 56
Renal involvement in Churg-Strauss syndrome. 56
Low doses of subcutaneous interleukin-2 plus interferon-alfa do not induce thyroid function alterations in advance renal cell carcinoma 55
Changes in lymphocyte count induced by repeated cycles with low-dose interleukin-2 and interferon-α in 146 patients with renal cell carcinoma. 55
IL TRAPIANTO DI RENE-PANCREAS COMBINATO. RISULTATI DEL CENTRO DI PARMA. 55
Diagnosis of Churg-Strauss syndrome: eotaxin-3 makes it easier. 54
Association between idiopathic retroperitoneal fibrosis and autoimmune thyroiditis: A case–control study 54
Prevalence of autoantibodies against structure specific recognition protein 1 in systemic lupus erythematosus 54
Membranous glomerulonephritis after haematopoietic cell transplantation for multiple myeloma 53
Effect of conjugated estrogens on free IGF-I? 53
Ipertrofia ventricolare sinistra e sistema nitrossidergico miocardio nella fase pre-ipertensiva del modello sperimentale SHR 53
Calciphylaxis: evolving concepts. 53
Immunoterapia (IT) combinata a basse dosi nel carcinoma renale a cellule chiare (RCC) metastatico 53
Antifibroblast antibodies from systemic sclerosis patients are internalized by fibroblasts via a caveolin-linked pathway 53
L’interessamento renale nelle vasculiti sistemiche. La granulomatosi di Wegener 52
Tuberculosis as a trigger of retroperitoneal fibrosis 52
Tamoxifen vs prednisone in patients with retroperitoneal fibrosis:preliminary results of a randomised clinical trial 52
Significato prognostico di alcuni parametri immunologici in pazienti con carcinoma a cellule renali metastatico trattati con dosaggi molto bassi di rIL-2 e rIFNa 52
Alterazioni renali correlate con l’artrite reumatoide 52
Long-term immunotherapy with low-dose interleukin-2 and interferon-alpha in the treatment of patients with advanced renal cell carcinoma 51
Eosinophils and C4 predict clinical failure of combination immunotherapy with very low dose subcutaneous interleukin-2 and interferon in renal cell carcinoma patients 51
Inquadramento clinico delle vasculiti sistemiche 50
HCV-RELATED CRYOGLOBULINEMIC GLOMERULONEPHRITIS: IMPLICATIONS OF ANTIVIRAL AND IMMUNOSUPPRESSIVE THERAPIES 50
Rhinologic manifestations of small-vessel systemic vasculitides. 50
Rituximab therapy for chronic periaortitis. 50
“Late” regression of metastases from renal cancer after a period of disease progression continuing the same intermittent low dose immunotherapy regimen 50
Occupational risk factors for renal cell cancer. An Italian case-control study 49
FDG-PET in idiopathic retroperitoneal fibrosis 49
Peri-renal collateral circles. 49
Reply to “Is chronic autoimmune thyroiditis a systemic disease?” 49
Fibrosi retroperitoneale e vasculite dei piccoli vasi 48
THE ROLE OF HLA POLYMORPHISMS IN SUSCEPTIBILITY TO CHURG-STRAUSS SYNDROME AND THEIR INFLUENCE ON DISEASE PHENOTYPE 48
Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-alpha for metastatic renal cell cancer 48
Chronic periaortitis and autoimmune thyroiditis: A novel association 48
Long-term outcome and clinical significance of orthostatic proteinuria. 47
Totale 6.575
Categoria #
all - tutte 28.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.446


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.687 0 317 136 40 184 237 253 42 162 132 42 142
2020/2021963 12 143 115 7 133 18 125 11 197 34 159 9
2021/2022691 8 14 3 40 16 12 106 131 36 55 73 197
2022/20232.453 302 227 132 189 254 268 25 132 829 7 66 22
2023/2024673 42 79 20 20 67 187 21 67 14 41 39 76
2024/202585 75 10 0 0 0 0 0 0 0 0 0 0
Totale 8.551